pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·1d ago·1 min read
save

EMA launches consultation on draft framework to speed adoption of data standards

Aug 20, 2026·read at raps ↗RegulatoryNeutral

EMA has opened a public consultation on a draft framework aimed at accelerating the implementation of data standards across the pharmaceutical sector.

The agency says the new framework is intended to reduce the time required for companies to adopt standardized data formats, which could streamline regulatory submissions and improve data sharing.

Stakeholders are invited to submit comments during the consultation period, after which the EMA will refine the guidance before final adoption.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Euro Roundup: EMA seeks feedback on framework designed to drive uptake of data standards”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1d agoRecon: FDA approves Ultragenyx gene therapy for glycogen storage disorder; Overton faces confirmation challengesraps
  • 1d agoExperts discusses need to modernize evidentiary models in rare diseasesraps
  • 1d agoFDA finalizes Q&A guidance on developing cell and gene therapiesraps
  • 2d agoTrump taps Heidi Overton as next FDA Commissionerraps
  • 3d agoRecon: FDA releases draft guidance on gen AI-enabled devices; Industry warns Germany must reform drug pricingraps